Hematology

The Pharmacy Times® Hematology Resource Center is a comprehensive resource for clinical news and expert insights on the treatment of blood disorders, include blood and bone marrow cancers, anemia, hemophilia, blood-clotting disorders, and leukemia.

Latest News

Lab scientist looking blood samples -- Image credit: Анна Ковальчук | stock.adobe.com
Study Results Show Evolving DNA Methylation Can Help Understanding of Hematologic Diseases

March 18th 2024

The authors note that understanding the DNA methylation profile in leukemia can help predict whether or not a patient will respond to treatment.

FDA approval stamp -- Image credit: waldemarus | stock.adobe.com
FDA Approves Liso-Cel Therapy for Treatment of Adult Patients With CLL, SLL

March 15th 2024

Bone marrow transplant -- Image credit: Vadim | stock.adobe.com
Medical Non-Compliance Post-BMT in Pediatric Patients Associated With Annual Income, Insurance Status

March 11th 2024

FDA Grants Accelerated Approval to Zanubrutinib for Relapsed, Refractory Follicular Lymphoma
FDA Grants Accelerated Approval to Zanubrutinib for Relapsed, Refractory Follicular Lymphoma

March 7th 2024

Lymphoma Cancer Cell Hematology | Image Credit: catalin - stock.adobe.com
FDA Grants Priority Review to Epcoritamab-bysp for Relapsed or Refractory Follicular Lymphoma

February 28th 2024

Video Series
Video Interviews
Podcasts
Latest CME Events & Activities

Risks and Liabilities in Pharmacy Practice

1.0 Credit / Law

View More

CAR T-Cell Therapy Advances in Lymphoma: Implications for Managed Care

1.5 Credits / Hematology, Oncology

View More

Evidence-Based Oncology: Discerning Novel Approaches, Recent Advances, and the Managed Care Considerations for Targeted Treatments in CLL

2.0 Credits / Hematology, Oncology

View More

Leveraging Managed Care to Increase Access to BCMA-Directed Treatment and Equitable Care in Multiple Myeloma

1.5 Credits / Hematology, Oncology

View More

Leveraging Managed Care to Optimize Patient Outcomes in Acute Myeloid Leukemia

1.5 Credits / Hematology, Oncology

View More

New Pathways in Care for Myelofibrosis: Optimizing Treatment to Improve Outcomes

1.5 Credits / Hematology, Oncology

View More

Translating Progress in BCMA-Directed Therapy for Multiple Myeloma into Advances in Patient Care

1.0 Credit / Hematology, Oncology

View More

Ushering in a New Era of Targeted Therapies in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Focus on New and Emerging Antibody-Based Regimens

1.0 Credit / Hematology, Oncology

View More

Optimizing Outcomes for Older Patients With Acute Myeloid Leukemia: A Focus on Alternative Induction Regimens and Maintenance Therapy

1.0 Credit / Hematology, Oncology

View More

Treatment Strategies for Chronic Myeloid Leukemia and the Pharmacist’s Impactful Role

1.0 Credit / Hematology, Oncology

View More

Enhancing the Safety of Outpatient CAR T-Cell Administration in Relapsed/Refractory Lymphomas Through Pharmacist-Directed Initiatives

1.0 Credit / Hematology, Oncology

View More

Continuing the Conversation in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Addressing Operational Challenges and Integrating New and Emerging Antibody-Based Regimens

1.0 Credit / Hematology, Oncology

View More

Navigating Current and Emerging Treatment Options for Myelofibrosis After Frontline Failure

1.0 Credit / Oncology

View More

Managed Care Considerations on the Evolving Role of Bispecific Antibodies in Hematologic Malignancies

1.5 Credits / Hematology, Oncology

View More

Continuing the Conversation in Myelofibrosis: The Role of Managed Care in Supporting Treatment Goals Through Appropriate Use of Emerging Therapies

1.0 Credits / Hematology, Oncology

View More

Caring for Patients With Chronic Graft-versus-Host Disease: The Important Role of Pharmacists on the Cancer Care Team

1.5 Credits / Hematology, Oncology

View More

New Frontiers in the Treatment of Lower-Risk Myelodysplastic Syndromes and the Role of Oncology Pharmacists

1.5 Credit / Hematology, Oncology

View More

Advancing Myelofibrosis Treatment and Management With JAK Inhibitors and Specialty Pharmacist-led Strategies

1.5 Credits / Hematology

View More

Clinical Updates in AML Induction and Maintenance Regimens and the Role of the Specialty Pharmacist

1.5 Credit(s) / Hematology, Oncology

View More

Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns

1.0 Credit / Law

View More

Supporting Safe, Effective, and Equitable Access to B-Cell Maturation Antigen (BCMA)-Directed Treatments in Multiple Myeloma: Strategies for Specialty and Managed Care Pharmac...

1.5 Credit / Hematology, Oncology

View More

Exploring the Advancements in BTK Inhibitor Therapy for Mantle Cell Lymphoma and the Growing Impact of Oncology Pharmacists

1.0 Credit / Hematology, Oncology

View More

Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications

1.5 Credits / Law, Oncology

View More

Advances in the Treatment of Myelofibrosis: Updates and Considerations for Managed Care Professionals

1.0 Credit / Hematology, Oncology

View More

Assessing Emerging Therapies and Multidisciplinary Practices in Managing Myelofibrosis

1.5 Credits / Hematology, Oncology

View More

Chronic Myeloid Leukemia: Navigating Drug Resistance and Optimizing Care

1.0 Credit / Hematologic Cancer, Hematology, Oncology

View More

Optimizing Use of Small Molecule Inhibitors in Chronic Lymphocytic Leukemia: Strategies for Safe and Effective Use

1.0 Credits / Hematology, Oncology

View More

Child Abuse: Responsibilities and Protection of the Reporter

1.0 Credit / Law

View More

Management of DOAC-Associated Bleeding With Reversal Agents: A Comprehensive Approach for Health-System Pharmacists

1.0 Credit / Hematology

View More

More News

© 2024 MJH Life Sciences

All rights reserved.